Amy W. Schulman - 14 Jun 2023 Form 4 Insider Report for SQZ Biotechnologies Co

Reporting relationship: Director, 10%+ Owner
Issuer ticker: N/A
Reported as of: 14 Jun 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Jun 2023, 16:46:40 UTC
Prior SEC filing: 19 May 2023
Next SEC filing: 01 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Lawrence Knopf as Attorney in Fact for Amy Schulman

Key filing fact

Amy W. Schulman filed Form 4 for SQZ Biotechnologies Co on 15 Jun 2023.

Key facts

This page summarizes Amy W. Schulman's Form 4 filing for SQZ Biotechnologies Co.
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 Jun 2023, 16:46.

Change

Previous filing in this sequence was filed on 19 May 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SQZB transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +39,875
Change %
Price: $0.000000
Shares after: 39,875
Date: 14 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 39,875
Exercise price: $0.5390
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests and become exercisable on the earlier of (i) June 14, 2024 or (ii) the day immediately prior to the date of the next annual meeting of stockholders following the date of grant, in each case subject to the recipient's continued service on the Board at such time.